Dimitrios Evangelopoulos

Dimitrios Evangelopoulos is a Lecturer in Microbiology at University College London's Department of Microbial Diseases within the UCL Eastman Dental Institute. He holds a PhD in Molecular Microbiology from Birkbeck, University of London and a B.Sc. in Molecular Biology and Genetics from Democritus University of Thrace, Greece. His academic career includes significant research positions at the Francis Crick Institute and UCL's Centre for Clinical Microbiology as part of the European PreDiCT-TB consortium.

His educational background includes:

• PhD in Molecular Microbiology, Birkbeck, University of London (2011)
• B.Sc. in Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupoli, Greece (2006)

Dr. Evangelopoulos' research primarily focuses on antimicrobial resistance mechanisms in tuberculosis, with particular emphasis on drug discovery and development of molecular biomarkers for bacterial load quantification. His work bridges fundamental microbiology with clinical applications, exploring transcriptomic signatures of drug action in Mycobacterium tuberculosis and investigating novel antibiotic strategies. He has expanded his expertise to include SARS-CoV-2 diagnostics during the recent pandemic, demonstrating adaptability in addressing emerging infectious disease challenges.

Analysis of his publication record reveals a strong focus on tuberculosis drug discovery and resistance mechanisms, with recent expansion into diagnostic methodologies and pandemic response. His work demonstrates an interdisciplinary approach combining microbiology, biochemistry, and molecular biology to address antimicrobial resistance challenges. The publications show consistent progression from basic research on mycobacterial drug targets to translational applications in drug development and diagnostic tools.

Professional memberships include:

• Full member of Microbiology Society (since 2011)
• Elected member of Acid Fast Club (since 2012)
• Member of British Society for Antimicrobial Chemotherapy (since 2015)

Dr. Evangelopoulos actively supervises research degrees and taught course research projects, with teaching responsibilities spanning undergraduate and postgraduate programs. His teaching portfolio includes modules on medical bacteriology, drug discovery, and research methods. His research program, established at UCL Eastman Dental Institute in 2019, continues to investigate antimicrobial resistance while contributing to collaborative drug discovery projects.

He leads research within the Department of Microbial Diseases, focusing on antimicrobial resistance mechanisms and drug discovery approaches against Mycobacterium tuberculosis. His laboratory applies interdisciplinary methods including metabolomics, transcriptomics, and molecular biology techniques to investigate novel antibiotic strategies and resistance mechanisms.